Proteus Biomedical, Inc. Raises $17.5 Million
Published: May 17, 2012
The Funded is a recurring feature where we post new fundings that cross our desks, as well as an archive of past fundings.
Proteus Biomedical Inc. raises $17.5M of $50M round
The Redwood City-based health care company sold equity to raise the funds. The parties listed on the filing include: Joy Berberich, executive; Benjamin Costello, executive; Lorenzo Di Carlo, executive; Frank Fischer, director; Terry Gould, director; Erika Karplus, executive; Alan Levy, director; David O'Reilly, executive; Ben Pless, director; Timothy Robertson, executive; George Savage, executive; Ryan Schwarz, director; Immanuel Thangaraj, director; Andrew Thompson, executive, director; Todd Thompson, executive; Mark Zdeblick, executive, director.
Proteus is a private company. Its investors include: Adams Street Partners, Asset Management, The Carlyle Group, Essex Woodlands, Fletcher Spaght Ventures LP, Kaiser Permanente Ventures and Spring Ridge Ventures. The company makes digestible sensors made from food ingredients, which can record information such as a drug type or dosage.